Invokana Injury Lawsuits
Invokana (canagliflozin), Invokamet (canagliflozin and metformin), and Invokamet XR (canagliflozin and metformin hydrochloride extended-release) are prescription drugs used in the treatment of Type 2 diabetes. But patients who take these drugs may face an increased risk of developing serious illnesses, including Fournier’s Gangrene, bladder cancer, and renal cancer.
You may be entitled to compensation if you lost a loved one who took Invokana, Invokamet, or Invokamet XR, or you suffered any of the following injuries or illnesses after taking one of the drugs:
- Fournier’s Gangrene
- Kidney failure
- Bladder cancer
- Renal cancer
At Ferrer, Poirot & Wansbrough, our drug injury lawyers are here to protect your rights. We’ve recovered millions of dollars* for injury victims across the United States, and we have the resources and experience to help you get the compensation you need. Dial (800) 210-8503 or complete our free online form to get started now.
Invokana, Invokamet, and Invokamet XR Linked to Gangrene
Invokana, Invokamet, and Invokamet XR are sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of medications used to treat Type 2 diabetes. SGLT2 inhibitors help to lower a patient’s blood sugar by preventing the kidneys from absorbing glucose and helping them eliminate sugars through the urine.
On September 29, 2018, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication explaining that SGLT2 inhibitors such as Invokana, Invokamet, and Invokamet XR have been linked to cases of necrotizing fasciitis of the perineum, also known as Fournier’s Gangrene, a serious infection of the genitals and their surrounding areas. In response, the FDA has required new warnings be added to prescription information and the patient Medication Guide.
The rare but life-threatening bacterial infection affects the muscles, nerves, tissue, and blood vessels in the genital and anal areas. Symptoms of Fournier’s Gangrene include:
- Swelling, redness, or tenderness of the genitals
- Fever of 100.4 degrees Fahrenheit or higher
- General malaise
Patients who experience these side effects should seek medical attention immediately, as the symptoms can progress quickly. If you or a loved one developed Fournier’s Gangrene while taking Invokana or Invokament, you may be entitled to significant compensation, and the attorneys at Ferrer, Poirot & Wansbrough want to help. Don’t wait—call us 24/7 at (800) 210-8503.
Invokana and Invokamet May Cause Bladder and Renal Cancers
In June 2016, the FDA issued a Drug Safety Communication regarding the increased risk of kidney injury in patients taking Invokana and Invokamet, among other SGLT2 inhibitors. Acute kidney injury occurs when the kidneys stop working properly and can lead to an increased buildup of waste within the body.
Recent studies have also shown an increased risk of bladder and kidney cancers in patients taking SGLT2 inhibitors. However, no prescription information or warnings indicate the potential link.
Symptoms of Bladder and Renal Cancers
Symptoms of bladder cancer may include:
- Blood in the urine
- Frequent and/or painful urination
- Pelvic pain
Symptoms of renal cancer may include:
- Blood in the urine
- Lower back pain on one side
- Weight loss
- Pain or swelling in the abdomen
Patients who experience signs of bladder or renal cancers while taking Invokana, Invokamet, or other SGLT2 inhibitors should seek medical attention immediately.
Our Nationwide Invokana Lawyers Want to Help
Ferrer, Poirot & Wansbrough believes in reforming the pharmaceutical industry through litigation, and we want to fight for you. There are strict deadlines for filing drug injury lawsuits, so don’t wait to get help if you or a loved one suffered complications, such as gangrene, bladder cancer, or renal cancer, after taking Invokana, Invokamet, or Invokamet XR. Contact our 24/7 legal team anytime–just dial (800) 210-8503 or complete a free initial consultation form.
Invokana® and Invokamet® are registered trademarks of Janssen Pharmaceuticals, Inc.
This law firm is not associated with, sponsored by, or affiliated with Janssen Pharmaceuticals, Inc., or the U.S. Food and Drug Administration.
*Zyprexa, Seroquel and Avandia gross settlements; attorney fees and expenses deducted.